In Australia and EuropeMADRID and CAMBRIDGE, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY),…
In Australia and EuropeMADRID and CAMBRIDGE, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY),…
EL PASO, TX / ACCESS Newswire / September 13, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based…
BOSTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing treatments for neurological disorders and neuro-oncology,…
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media…
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives…
Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum…
A clinically validated screening tool, now redesigned for parents with AI support and instant results at home. ATLANTA, Aug. 25, 2025 /PRNewswire/ -- Neo Sophia today announced the launch…
AUSTIN, TX / ACCESS Newswire / August 22, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based applied…
AUSTIN, TX / ACCESS Newswire / August 21, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based applied…